27 April 2021>: Clinical Research
The Effects of Obesity on Mortality Following Coronary Artery Bypass Graft Surgery: A Retrospective Study from a Single Center in China
Mengwei Lv 12BDF* , Fei Gao 3BCD* , Ban Liu 4DEF* , Pratik Pandey 4EF , Yipeng Feng 5BC , Yingwei Wang 6BC , Yangyang Zhang 1ADFG* , Zhi Li 7ADE*DOI: 10.12659/MSM.929912
Med Sci Monit 2021; 27:e929912
Table 3 Univariate and multivariate Cox regression analysis.
Variables | Univariate Cox regression | Multivariate Cox regression | ||
---|---|---|---|---|
HR | P value | HR | P value | |
Sex | 0.986 (0.597–1.629) | 0.956 | 0.936 (0.561–1.561) | 0.801 |
Age (y) | 1.127 (1.090–1.164) | 1.113 (1.077–1.150) | ||
BMI (kg/m) | 0.952 (0.880–1.029) | 0.215 | 0.974 (0.900–1.055) | 0.522 |
BSA (m) | 0.670 (0.172–2.615) | 0.564 | ||
Types of CAD | 0.926 (0.673–1.275) | 0.639 | ||
Diabetes mellitus | 1.337 (0.861–2.077) | 0.196 | ||
Hypertension | 1.067 (0.664–1.713) | 0.789 | ||
Cerebrovascular disease | 1.565 (1.080–2.266) | 0.018 | 1.337 (0.911–1.963) | 0.138 |
Peripheral vascular disease | 0.723 (0.100–5.199) | 0.747 | ||
Preoperative atrial fibrillation | 1.113 (0.273–4.532) | 0.881 | ||
Pulmonary hypertension | 3.237 (1.666–6.291) | 0.001 | 2.319 (1.167–4.609) | 0.016 |
Scrum creatinine (μmol/l) | 1.003 (1.001–1.005) | 0.013 | ||
Ccr (mL/min/1.73 m) | 0.972 (0.963–0.982) | |||
Renal failure | 4.180 (1.015–17.047) | 0.048 | 2.492 (0.576–10.783) | 0.222 |
LVEF | 0.982 (0.957–1.008) | 0.183 | ||
Triple vessel disease | 1.472 (0.705–3.075) | 0.303 | ||
COPD | 0.666 (0.092–4.793) | 0.686 | ||
Previous PCI | 0.275 (0.038–1.975) | 0.199 | ||
NYHA | 1.692 (1.209–2.370) | 0.002 | 1.393 (0.985–1.969) | 0.061 |
Types of CABG | 0.192 (0.097–0.382) | 0.233 (0.117–0.465) | ||
BMI – body mass index; BSA – body surface area; CAD – coronary artery disease; Ccr – creatinine clearance rate; LVEF – left ventricular ejection fraction; COPD – chronic obstructive pulmonary disease;PCI – percutaneous coronary intervention; NYHA – New York Heart Association; CABG – coronary artery bypass grafting. |